ciprofloxacin has been researched along with Myocardial Ischemia in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dichiara, AJ | 1 |
| Atkinson, M | 1 |
| Goodman, Z | 1 |
| Sherman, KE | 1 |
1 review available for ciprofloxacin and Myocardial Ischemia
| Article | Year |
|---|---|
Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Cellulitis; Cholestasis; Ciprofloxacin; Humans; Ja | 2008 |